InvestorsObserver
×
News Home

Should Adverum Biotechnologies Inc (ADVM) be in Your Portfolio?

Tuesday, October 27, 2020 01:30 PM | InvestorsObserver Analysts

Mentioned in this article

Should Adverum Biotechnologies Inc (ADVM) be in Your Portfolio?

Adverum Biotechnologies Inc (ADVM) is near the top in its industry group according to InvestorsObserver. ADVM gets an overall rating of 58. That means it scores higher than 58 percent of stocks. Adverum Biotechnologies Inc gets a 68 rank in the Biotechnology industry. Biotechnology is number 28 out of 148 industries.

Overall Score - 58
ADVM has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on ADVM!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 58 means the stock is more attractive than 58 percent of stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Adverum Biotechnologies Inc Stock Today?

Adverum Biotechnologies Inc (ADVM) stock has gained 0.84% while the S&P 500 has fallen -0.12% as of 1:21 PM on Tuesday, Oct 27. ADVM is up $0.10 from the previous closing price of $11.88 on volume of 234,690 shares. Over the past year the S&P 500 has risen 11.76% while ADVM is up 63.66%. ADVM lost -$1.21 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Adverum Biotechnologies Inc (ADVM) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App